Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

New Date for Median Technologies’ Webcasts: February 1st, 2024

January 26, 2024 at 11:46 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February 1, 2024:

Webcast held in English: at 4:30 pm CET / 10:30 am ET

> Registration link

Webcast held in French: at 6:00 pm CET / 12:00 pm ET

> Registration link

Webcast replays will be available on Median’s corporate website after the live sessions.

About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer and metabolic disease diagnoses and treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. Since its inception, the French-based company, with a presence in the U.S. and China, has been recognized as an "Innovative company" by BPI France and trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240126768143/en/

Contacts

Median Technologies

Emmanuelle Leygues

Head of Corporate Marketing & Financial Communications

+33 6 10 93 58 88

emmanuelle.leygues@mediantechnologies.com

Press - ALIZE RP

Caroline Carmagnol

+33 6 64 18 99 59

median@alizerp.com

Investors - ACTIFIN

Ghislaine Gasparetto

+33 6 21 10 49 24

ggasparetto@actifin.fr

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol

Price

Change (%)

AMZN

284.02

+0.00 (0.00%)

AAPL

303.42

+0.00 (0.00%)

AMD

484.64

+0.00 (0.00%)

BAC

62.48

+0.00 (0.00%)

GOOG

372.47

+0.00 (0.00%)

Get intelligentvalue.com

intelligentvalue.com

Safe & Secure

Fast Transfer

Flexible Payments

New Date for Median Technologies’ Webcasts: February 1st, 2024

Contacts

More News

Recent Quotes